Considering the current levels versus the highs of last June is like looking in the rear mirror, useful at times but quite useless in realizing what could lay ahead.IMO, expect the unexpected from BOT in 2019. News shall start flowing soon and - apart from those pertaining to trials - this could be the year that a sees a deal for Permetrex and possible partnerships coming to the fore.
Consider that kind of odd announcement on the 5th of December: what was that about? Another 'investors presentation" 3 weeks after the last one? ........It mentioned ..."investors, strategic partners and brokers in Canada". Why would they go to Canada if there wasn't something "cooking" there?
A 200M+ MC with good data from the trials - in this market - is a down-to-earth expectation, one that could be exceeded by the unexpected.
Got to love the market and the opportunities that it creates.
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-182
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.005(1.59%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.5¢ | 31.0¢ | $1.169M | 3.655M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 274982 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 48600 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
